Christopher J Morabito
Chief Tech/Sci/R&D Officer bei ASTRIA THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Aktive Positionen von Christopher J Morabito
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15.07.2022 | - |
Karriereverlauf von Christopher J Morabito
Ehemalige bekannte Positionen von Christopher J Morabito
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 10.05.2021 | 13.07.2022 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Chief Tech/Sci/R&D Officer | 01.10.2016 | 01.07.2020 |
| MERCK & CO., INC. | Director/Board Member | 01.10.2010 | 01.04.2014 |
Cardurion Pharmaceuticals LLC
 Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | - | - |
Ausbildung von Christopher J Morabito
| Franklin & Marshall College | Undergraduate Degree |
| Penn State Hershey College of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Japan | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Christopher J Morabito
- Erfahrung
